Advertisement
Screener

10x Genomics, Inc. (TXG) Additional Paid in Capital, Common Stock

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Additional Paid in Capital, Common Stock

10x Genomics, Inc. (TXG) had Additional Paid in Capital, Common Stock of $2.37 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-07

  • 2026-06-30: Additional Paid in Capital, Common Stock $2.37B.
  • 2026-03-31: Additional Paid in Capital, Common Stock $2.34B.
  • 2025-12-31: Additional Paid in Capital, Common Stock $2.31B.
  • 2025-09-30: Additional Paid in Capital, Common Stock $2.28B.
Period endAdditional Paid in Capital, Common Stock
2026-06-30$2.37B
10-Q · filed 2026-08-07
2026-03-31$2.34B
10-Q · filed 2026-05-08
2025-12-31$2.31B
10-Q · filed 2026-08-07
2025-09-30$2.28B
10-Q · filed 2025-11-07
2025-06-30$2.24B
10-Q · filed 2025-08-08
2025-03-31$2.21B
10-Q · filed 2025-05-09
2024-12-31$2.18B
10-K · filed 2026-02-13
2024-09-30$2.14B
10-Q · filed 2024-10-29
2024-06-30$2.11B
10-Q · filed 2024-08-08
2024-03-31$2.06B
10-Q · filed 2024-04-30
2023-12-31$2.03B
10-K · filed 2025-02-13
2023-09-30$1.98B
10-Q · filed 2023-11-03
2023-06-30$1.94B
10-Q · filed 2023-08-04
2023-03-31$1.88B
10-Q · filed 2023-05-04
2022-12-31$1.84B
10-K · filed 2024-02-15
2022-09-30$1.79B
10-Q · filed 2022-11-03
2022-06-30$1.76B
10-Q · filed 2022-08-09
2022-03-31$1.71B
10-Q · filed 2022-05-05
2021-12-31$1.68B
10-K · filed 2023-02-16
2021-09-30$1.64B
10-Q · filed 2021-11-05
2021-06-30$1.61B
10-Q · filed 2021-08-06
2021-03-31$1.57B
10-Q · filed 2021-05-07
2020-12-31$1.54B
10-K · filed 2022-02-18
2020-09-30$1.21B
10-Q · filed 2020-11-12
2020-06-30$714.63M
10-Q · filed 2020-08-12
2020-03-31$692.62M
10-Q · filed 2020-05-12
2019-12-31$682.49M
10-K · filed 2021-02-26
2019-09-30$676.84M
10-Q · filed 2019-11-12
2018-12-31$11.16M
10-K · filed 2020-02-27